Written by Kim Hobbs,

If you go to a hospital or to the mall, you see all the people working there walking around all the time. And all of them seem like they’re okay doing it. The sales associates aren’t limping, the nurses aren’t holding their backs because they’re in pain; it doesn’t seem that bad. Yes, they spend all their shift on their feet, but it seems like they’re used to it.

But can you ever get used to it, though? Well, you can’t (and you shouldn’t). 

Spending the vast majority of your shift standing up can’t be comfortable, and the shoes you wear usually make the whole situation worse.

There’s not enough talk about the amount of stress a doctor’s or a warehouse worker’s feet put up with every day, and there’s certainly not enough talk about how to help them. That’s because they think they have no other choice but to suck it up and live with it.

That makes no sense. How can you even work properly if your entire body, starting with your feet, hurts? Because that’s exactly what happens – first your feet start to ache, and by the time you go home, everything up to your neck is in pain. 

Let’s see why and what to do about it.

Every Shift Starts With Your Feet

Whenever you decide to move somewhere, it starts with the floor. 

Take nurses, for example. You don’t see them hanging around their desk all day, do you? They’re always going somewhere, and it all happens on that awful hospital floor. 

That’s not easy on their feet, especially if you take into account the fact that their shifts sometimes last for half a day. What people usually don’t think of is how much everything they do depends on their feet. The feet are the base of your body, and when they don’t feel good, nothing else does. That might seem like an overstatement, but believe it or not, that burning pain you feel on your heel could cause your back to hurt a couple of hours later.

And let’s talk about the floors a little because those sure don’t help. 

Wherever you look, you see tiles and concrete, which aren’t exactly known for absorbing impact. But that impact has to go somewhere, and if the floor doesn’t absorb it, your body has to. That’s why every step you take sends a little shock right through your heel and up into the rest of your body. And don’t think that you have to take a hit in order to have problems because you don’t.

You’re not aware of it, but your body takes tens of thousands of hits over time, and when you add those up, it becomes painfully obvious why it wears you down at some point.

So, what do people do in order to help themselves? 

They look for the fluffiest-looking shoes because cushioning seems like the obvious answer. And it is, for about an hour. 

After that, the weight of your body compresses all that cushioning, and it becomes pretty much useless. Instead of cushioning, you should be looking for support.

If you’re dealing with plantar fasciitis, flat feet, high arches, metatarsalgia, bunions, or just deep heel fatigue, orthotic shoe insoles – such as those produced by PCSsole Insoles – can be of great help. This is because orthotic insoles combine firm arch support and shock absorption, which is exactly what you need to stay both stable and comfortable. 

The idea for these soles is to give your feet a good base because that’s what prevents your body from working against itself.  

Where Long Shifts Cause the Most Problems

You’ll hear everyone complain about back pain and sore shoulders, but what they don’t know is that most trouble starts lower than that. Your feet take a real beating during long shifts, but the problems that come from that aren’t obviously rooted in the feet.

Standing Is Harder Than It Looks

You’d think walking is harder on your body than standing, but that’s not really true. If you stand for hours in one spot, the muscles in your legs stay tense so that your body can stay upright. When you walk, however, the movement gives your muscles a break, whereas standing doesn’t give you the chance to shift the weight from one foot to the other.

At the same time, the soft tissue under your feet gets squashed flat from the weight of your body, which cuts off circulation and presses on the nerves. 

That’s why you get that hot, tingly feeling after you’ve been standing for a few hours.

Small Changes in the Position of Your Feet Affect Every Step

Here’s something that probably never crossed your mind. 

Do you know that the arches of your feet are supposed to hold their shape as you walk? Without good support, though, that can’t happen. Your arches get flat, and your ankles roll in. To be clear, it’s only a little roll, but it changes so much.

Because of this, the knees twist off their natural track, the hips drop to balance things out, and the lower back has to curve so that your torso can stay steady. Sometimes, even the shoulders round forward. 

You won’t notice your body doing any of this, but your muscles sure will, and by lunchtime, your back will be in pain.

Repetition Causes Most Fatigue

You won’t get wiped out from one bad step. The real issue is in doing the same thing again and again. 

Look at a nurse; they can walk 4 or 5 miles during a single shift. A warehouse worker will easily hit 10,000 steps without even thinking about it. As healthy as walking is, every single step sends a shock through your body, and those shocks add up after a few hours.

You start to feel pain in your knees, your heels feel like they’re bruised, your lower back gets tight, and overall, you start to feel drained and achy all over. 

The worst part about this is that it’s relentless. That’s what exhausts you.

Fatigue Doesn’t Stay in Your Feet

If your feet hurt, your body will change how it moves so it can avoid pain as much as possible. You might start to walk with a little limp or shift the weight outside the edges of your feet.

Your hips could start to rock more than they should, your shoulders could lean forward, and so on. The point is, your body starts making little changes that take the pressure off your feet, but that causes issues at the same time because they make your body stop moving in a natural way. 

The exhaustion started at your feet, but after a couple of hours, it spread throughout your entire body.

The Workers Who Depend Most on Proper Foot Support

Even if you haven’t been diagnosed with any foot problems, you still need proper support. 

Anyone who spends hours on their feet every day absolutely must have footwear with good support; otherwise, your whole body will pay the price.

Medical Staff

Nurses, doctors, nursing assistants, surgical techs – these people spend almost entire shifts on their feet. 

A shift can last for 12 hours, and during that time, they’ll walk miles of tile corridors, stand at bedside monitors, and so on. They have hardly any chance to sit down, and those floors are not kind to their feet. They’re always moving around, and when you combine that with hard surfaces, it becomes obvious that healthcare workers put a tremendous amount of stress on their feet, and it’s even more obvious why proper footwear is an absolute necessity. 

Good arch support not only absorbs the shock, but also keeps everything from the ankles up aligned.

Workers in Distribution and Warehouses

Working in a warehouse involves a whole lot more than just lifting boxes. It’s not rare that the workers end up walking several miles during every shift between aisles, pulling orders, staging products, and you guessed it – lifting boxes. There’s absolutely no cushioning on that concrete floor, and with the fast pace, who has the time to slow down?

Supportive insoles can obviously be a big help here because they can take that annoying sting out of each step.

Retail Associates

Retail workers are on their feet all day, too, and their floors aren’t exactly comfortable. The stores are always busy, so there’s never enough time to sit down and rest properly. By the middle of the shift, their heels are burning, and arches are hurting like crazy.

Once again, proper support to the rescue. Good arch support will keep the feet in their natural position, and it’ll also help with posture.

And better posture means less pain in the shoulders and the neck.

Conclusion

Workplace ergonomics is actually a topic that gets a decent amount of attention, but the problem is that everyone focuses on pretty much everything except feet. That’s your real starting point, though. Every step you take starts with the feet, as does every pivot and every moment of standing up. 

So, it makes sense to think twice about what type of footwear you’re wearing to work every day.

Look down right now. What’s on your feet? Is it something that supports them or just covers them up?

Author Bio

Ms. Kim Hobbs an accomplished writer, storyteller, and creative thinker whose passion for the written word has captivated readers worldwide. With a keen eye for detail and a gift for weaving compelling narratives, Kim explores themes of resilience, transformation, and the human experience.She believes that every story has the power to change perspectives and spark meaningful connections.

Please also review AIHCP’s Health Care Certification program and CE courses see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

Written by Harry Wolf,

Mitochondrial Signaling and Metabolic Regulation: Emerging Insights in Cellular Research

Mitochondria are no longer viewed solely as bioenergetic organelles. No. Over the past decade, research has established them as central signaling platforms – shaping gene expression, stress adaptation, immune modulation, and metabolic control. 

For clinicians and researchers working across metabolic, cardiovascular, and neurodegenerative domains, understanding mitochondrial signaling is becoming pretty essential.

Mitochondrial Signaling in Metabolic Regulation

Metabolic regulation was once framed as a largely cytosolic and endocrine process. Contemporary evidence positions mitochondria as upstream regulators capable of transmitting stress and energetic cues directly to the nucleus.

Investigators at the University of Cambridge’s Medical Research Council Mitochondrial Biology Unit describe mitochondrial retrograde signaling as a coordinated communication pathway – which adjusts nuclear gene expression in response to mitochondrial dysfunction or metabolic demand. 

Changes in membrane potential, reactive oxygen species, and metabolite flux – they can all initiate transcriptional programs, which recalibrate cellular metabolism.

For practitioners managing chronic metabolic disease, such cross-talk offers insight into why mitochondrial impairment often coexists with:

• Insulin resistance
• Altered lipid handling
• Systemic inflammation

Several upstream signals are consistently implicated. They include:

• Altered mitochondrial membrane potential
• Accumulation of reactive oxygen species
• Perturbations in NAD+ and AMP levels
• mtDNA instability and release

Each of those inputs can activate adaptive nuclear programs that modify substrate utilization and energy efficiency.

Retrograde Signaling Pathways and Tissue-Specific Effects

Retrograde signaling is not uniform across tissues. Pancreatic β cells, hepatocytes, adipocytes, skeletal muscle, and cardiomyocytes all demonstrate distinct transcriptional outputs – and that’s despite shared upstream mitochondrial cues.

A 2023 analysis published in Nature highlights how mtDNA integrity and mitochondrial quality control influence metabolic phenotype in tissue-specific ways. 

When mitochondrial quality control pathways are disrupted, cells may shift substrate preference, alter oxidative capacity, or activate stress-response transcription factors – such as ATF4 and ATF5.

Emerging evidence also connects mitochondrial retrograde signaling to epigenetic regulation. According to a 2026 review by Science Direct, metabolites generated within mitochondria – including acetyl-CoA and α-ketoglutarate – can directly influence chromatin remodeling. 

The metabolic-epigenetic interface suggests that mitochondrial dysfunction may leave durable transcriptional imprints that extend beyond acute bioenergetic deficits.

Tissue-level consequences? They often include:

• Impaired insulin secretion in pancreatic β cells
• Reduced fatty-acid oxidation in skeletal muscle
• Altered lipid storage in adipose tissue
• Compromised stress resilience in cardiomyocytes

Such findings reinforce the view that mitochondrial signaling contributes to systemic metabolic phenotypes – rather than isolated organ dysfunction, that is.

Mitochondrial Dynamics and Metabolic Plasticity

Mitochondrial morphology… It is tightly linked to metabolic capacity. Fusion and fission events determine how:

• Efficiently substrates are oxidized
• Mitochondrial DNA is distributed
• Damaged components are segregated for removal

Research discussed in recent mechanistic analyses emphasizes that mitochondrial dynamics are not merely structural phenomena. 

Proteins – such as dynamin-related protein 1, mitofusin 1 and 2, and optic atrophy 1 – coordinate morphological remodeling in response to nutrient availability and energetic stress. 

Alterations in those proteins have been associated with both impaired oxidative phosphorylation and reduced metabolic flexibility.

Metabolic plasticity depends on coordinated shifts in mitochondrial architecture. Fragmented mitochondria are frequently observed in states of nutrient excess and oxidative stress. Whereas interconnected networks support efficient oxidative metabolism and substrate switching.

Key regulatory components include:

• Drp1-mediated fission facilitating segregation of damaged regions
• Mitofusin-dependent fusion supporting mtDNA complementation
• OPA1 regulation of inner membrane integrity and cristae structure
• Post-translational modifications that tune dynamic balance under stress

Clinical correlations continue to emerge. Dysregulated fission has been reported in obesity and insulin resistance. And impaired fusion has been implicated in cardiomyopathies characterized by energetic insufficiency. 

Appreciating how mitochondrial dynamics influence metabolic adaptability adds an important layer to understanding disease progression and therapeutic vulnerability – for healthcare professionals, that is. 

Mitochondrial-Derived Peptides and Nuclear Reprogramming

Now, let us turn our attention to mitochondrial-derived peptides. They represent an additional layer of intracellular communication beyond classical retrograde signaling pathways. 

Encoded within short open-reading frames of mitochondrial DNA, these peptides extend mitochondrial influence beyond bioenergetics and into:

• Transcriptional regulation
• Stress adaptation
• Systemic metabolic control

MOTS-c is a 16-amino-acid mitochondrial-derived peptide – encoded within the 12S rRNA region of mitochondrial DNA. It has been described as an endocrine-like signaling factor capable of nuclear translocation, where it influences metabolic gene expression programs. 

Experimental studies associate MOTS-c activity with the following: enhanced glucose uptake, improved insulin sensitivity, and modulation of inflammatory signaling through activation of AMP-activated protein kinase pathways.

In preclinical laboratory settings, the MOTS-C research peptide is frequently referenced when investigating mitochondrial-to-nuclear signaling mechanisms and metabolic stress adaptation.

Mechanistic analyses suggest that MOTS-c translocates to the nucleus under metabolic challenge – including nutrient excess and oxidative stress conditions. 

Once localized to the nucleus, it interacts with transcriptional regulators involved in antioxidant defense and metabolic remodeling. 

Research summarized in an article in MDPI describes how MOTS-c participates in stress-responsive signaling networks that influence glucose metabolism and redox homeostasis.

Experimental models have demonstrated activation of AMP-activated protein kinase signaling and downstream transcriptional reprogramming linked to energy balance. 

A clinical study published by the National Library of Medicine outlines an ongoing Phase 2a trial evaluating MOTS-c in adults with prediabetes and overweight or obesity – focusing on insulin sensitivity and pharmacodynamic markers. 

Such investigations represent a progression from mechanistic characterization toward structured translational evaluation.

Core mechanistic themes? They include:

• AMPK pathway activation during metabolic stress
• Nuclear translocation associated with gene-expression modulation
• Enhancement of cellular glucose uptake pathways
• Regulation of inflammatory and redox-responsive signaling networks

Organelle Cross-Talk and Integrated Metabolic Control

Mitochondrial signaling… It rarely occurs in isolation. Interactions with the endoplasmic reticulum, peroxisomes, and cytoskeletal elements all influence how metabolic information is processed.

Mitochondria-associated membranes facilitate calcium exchange and lipid transport – which are processes that directly affect ATP production and metabolic flexibility. 

Disruption in these contact sites has been linked to impaired excitation-metabolism coupling in skeletal muscle. And altered substrate utilization.

Mitochondrial stress can activate integrated stress responses that intersect with inflammatory signaling cascades. 

These intersections may help to explain why metabolic disorders seem to frequently present with low-grade chronic inflammation.

Metabolism encompasses the full spectrum of chemical reactions that sustain life – from ATP generation to biosynthesis. Integrating this broader clinical definition with emerging mitochondrial data clarifies how subcellular dysfunction can translate into systemic pathology.

What are key organelle interactions? Well, they include:

• Calcium flux between endoplasmic reticulum and mitochondria
• ROS-mediated signaling affecting cytosolic kinases
• Metabolite exchange influencing nuclear transcription
• Quality-control pathways linking mitophagy to metabolic adaptation

Mitochondrial QC and Mitophagy in Metabolic Disease

Metabolic regulation… It requires more than adequate ATP production. Preservation of mitochondrial integrity through quality-control systems is equally essential for sustained cellular performance.

Multiple reviews describe how mitochondrial quality control encompasses proteostasis, selective autophagy, and genome surveillance. 

The PINK1–Parkin pathway, for example, tags depolarized mitochondria for degradation- thus limiting propagation of dysfunctional organelles that generate excess reactive oxygen species.

Beyond mitophagy, the mitochondrial unfolded protein response coordinates transcriptional adaptation when misfolded proteins accumulate within the organelle. 

Nuclear-encoded stress-response genes are activated to restore proteostatic balance – linking organelle dysfunction directly to transcriptional reprogramming.

Here are some central quality-control processes:

• PINK1 stabilization on depolarized mitochondria initiating Parkin recruitment
• Ubiquitination of outer membrane proteins marking organelles for autophagic removal
• Activation of mitochondrial unfolded protein response transcription factors

Clinical implications extend across metabolic and cardiovascular disease. Impaired mitophagy has been associated with insulin resistance. And defective mitochondrial proteostasis contributes to cardiomyocyte vulnerability under ischemic stress. 

Integrating mitochondrial quality control into the broader framework of mitochondrial signaling and metabolic regulation strengthens mechanistic interpretation of disease trajectories – and supports more precise research hypotheses.

Implications Across Metabolic and Cardiovascular Disease

Mitochondrial signaling pathways increasingly appear in cardiovascular research. And metabolic research. 

A study published by the National Library of Medicine reported that MOTS-c administration in preclinical models attenuated oxidative stress. And it partially preserved mitochondrial enzyme activity during ischemia-reperfusion injury. 

Although mechanistic pathways require further validation, findings suggest that mitochondrial-derived peptides may influence cardiac stress responses.

In metabolic disease, altered mtDNA copy number and impaired mitochondrial biogenesis have been observed in individuals with insulin resistance and type 2 diabetes. And mitochondrial genomic stability contributes to metabolic resilience.

So, for clinicians managing cardiometabolic conditions, several translational themes are emerging:

• Mitochondrial quality control as a determinant of tissue resilience
• Retrograde signaling as a mediator of chronic metabolic adaptation
• Peptide-based signaling molecules as investigative targets
• Metabolic-epigenetic coupling influencing long-term outcomes

Such insights do not yet redefine clinical guidelines. But they do inform research priorities and therapeutic exploration.

Future Directions 

Research momentum suggests that mitochondrial signaling will remain central to metabolic science over the coming decade or so. Advanced imaging, metabolomics, and single-cell transcriptomics… They are all clarifying how mitochondrial states vary within and across tissues.

Ongoing clinical studies will help determine whether mitochondrial-derived signaling molecules translate into measurable metabolic improvements in humans. 

Refining methodological rigor will be essential. Standardization of mtDNA quantification, harmonization of bioenergetic assays, and longitudinal clinical phenotyping are needed to connect mechanistic signaling data with patient outcomes.

Advancing Clinical Understanding 

Mitochondrial signaling and metabolic regulation… They are no longer peripheral topics in cellular research. Evidence supports the view that mitochondrial communication networks influence systemic metabolic health.

So, explore ongoing research initiatives, review emerging data, and consider contributing to discussions within your institution or through specialized platforms to advance understanding in this rapidly evolving field. And check out related content on our site.

Author bio: Harry Wolf is a freelance writer. For almost a decade, he has written on topics ranging from healthcare to business leadership for multiple high-profile websites and online magazines.

References:

Schirrmacher, Volker. (2020). Mitochondria at Work: New Insights into Regulation and Dysregulation of Cellular Energy Supply and Metabolism. National Library of Medicine.

https://pmc.ncbi.nlm.nih.gov/articles/PMC7700424/

Meichsner, Anna, Bader, Verian, Winklhofer, Konstanze F. (2026). Mitochondria as sources and targets of cellular signaling. Science Direct.

https://www.sciencedirect.com/science/article/pii/S1097276526000286

Picard, Martin, Shirihai, Orian S. (2022). Mitochondrial signal transduction. Cell Metabolism: A Cell Press Journal.

https://www.cell.com/cell-metabolism/fulltext/S1550-4131(22)00459-4

Kim, Mi Eun, Lim, Yeeun, Lee, Jun Sik. (2025). Mitochondrial Dysfunction and Metabolic Reprogramming in Chronic Inflammatory Diseases: Molecular Insights and Therapeutic Opportunities. MDPI.

https://www.mdpi.com/1467-3045/47/12/1042

Chen, Wen, Zhao, Huakan, Li, Yongsheng. (2023). Mitochondrial dynamics in health and disease: mechanisms and potential targets. Nature.

https://www.nature.com/articles/s41392-023-01547-9

Unauthored. (Undated). Mitochondrial retrograde signalling. University of Cambridge MRC Mitochondrial Biology Unit.

https://www.mrc-mbu.cam.ac.uk/research-groups/ryan-group/mitochondrial-retrograde-signalling

Unauthored. (2024). Metabolism. Cleveland Clinic.

https://my.clevelandclinic.org/health/body/21893-metabolism

Hudson Biotech. (2026). MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/​Obesity (MOTS-MET). National Library of Medicine.

https://clinicaltrials.gov/study/NCT07505745

Please also review AIHCP’s Managed Health Care Certification program and CE courses see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

Written by Alex Morphy,

Electronic medical records (EMRs) have revolutionized the way healthcare providers manage, gather, and distribute patient data. Medical practices can now store vast quantities of confidential information online rather than on paper and retrieve it at any time. But digital records have their problems of security. Patient information can be shared as a result of cyberattacks, unauthorized access, data breaches, and accidental disclosure.

What is Data Encryption?

Data encryption is a process of making data hard to read or incomprehensible from plaintext (readable) to ciphertext (encoded). The encrypted information can only be converted back into its original form by someone with the appropriate decryption key.

In healthcare, encryption can be used for patient data security when it’s stored and when it’s transferred between systems.

Encryption at Rest

Encryption at rest is the security method used to protect information, whether it’s on the device, on the server, on the database, or on the cloud. Once an unauthorized user accesses a storage system, files are much more difficult to access without a decryption key.

If a health care organization stores patient data in a database, for instance, encryption can help protect the patient information stored on the database if the storage device is compromised or stolen.
Encryption in transit

Security of data as it is being transferred from one location to another. Healthcare providers often share patient data with other authorized individuals, such as other healthcare providers, pharmacies, insurance companies, and laboratories, among others, between computers, servers, and the like.

Secure encryption protocols help to ensure that the data is protected from being accessed while in transit over networks.

Why is it important to use encryption with an electronic medical record system?

Some of the more subtle information relating to the people is included in EMRs. Personal information, such as names, addresses, medical history, diagnoses, treatment details, insurance information and more can be found in a single patient record.

This security breach can wreak a great amount of harm on the patient and the health care organization.

Minimizing the risk of data breaches

Healthcare organizations often hold all the trimmings for cybercriminals to strike because of the information they typically store. Encryption is another level of security because if it is lost or stolen or intercepted, it is not as easy to use.

Though encryption is not a solution for all cyberattacks, it does limit the potential impact if a cyberattack succeeds in gaining access to sensitive information.

Protecting Patient Privacy

Doctors and other health care professionals are expected to keep patient information confidential. Robust encryption methods can help organizations protect this data from unauthorized access.

Encryption makes patient information more difficult for an unauthorized user to access or utilize.

Supporting HIPAA Compliance

The Health Insurance Portability and Accountability Act (HIPAA) sets forth regulations for healthcare companies in the United States dealing with protected health information (PHI). HIPAA provides guidelines to protect private patient information.

Encryption is a key element of an overall strategy of securing electronic PHI. When selecting an EMR system, organizations should look for a solution that has robust security measures and encryption features. Healthcare providers can also conduct a search for the best HIPAA-Compliant EMR software solutions and find one that meets their privacy and security needs when researching options.

How Encryption is used in EMR Systems.

There are multiple ways in which modern EMR platforms can provide data security across the healthcare data’s lifecycle.

Security of Stored Patient Data

Medical professionals typically keep extensive patient records in data centers and cloud systems. This data can be protected from unauthorized access using encryption.

Another way cloud-based EMR systems can protect information stored on their servers is through the use of encryption. But for healthcare organizations, it is important to consider a vendor’s security measures and its implementation of encryption.

Providing secure remote access

The use of remote access in the healthcare sector is increasingly prevalent. Authorities and doctors may require accessing information from patient records on multiple devices or places.

Encryption may be used to help secure information during remote sessions, and should be used in conjunction with other security measures like multi-factor authentication, access controls and secure device management.

Access Controls

Patient information must be accessed by only authorized employees. Role based access controls can restrict access to information based on users’ role in order to allow access to only the information that they need to do their job.

Regular Security Updates

The vulnerability in software can give rise to an opportunity for attackers. Security risks can be minimized by maintaining EMR platforms, operating systems, and connected devices up to date.

Employee Security Training

There is still the possibility of human error as a security threat. Similar to the other characters, regular training of healthcare employees should be conducted regarding password security, phishing attacks, social engineering, and handling patient information.

Let’s look at some of the things that healthcare organizations should consider.

Healthcare providers need to consider factors beyond mere functionality when choosing an EMR system. Security should be an important consideration throughout the decision-making process.

Organizations should seek out information from vendors on encryption, data storage methods, access control, authentication, backup, and data incident response. They should also assess if the vendor has the necessary documentation and agreements to deal with protected health information.

Conclusion

Encryption is one of the fundamental technologies used to defend electronic medical records in the modern digital healthcare surroundings. Encryption not only protects data while it is being transmitted but also when it is stored, helping to minimize the chances of unauthorized access or data breaches and contributing to overall patient privacy and security measures.

About the Author : Alex Morphy is a B2B content writer who specializes in creating clear, well-researched content for business audiences. His work focuses on breaking down complex subjects into simple, practical insights that readers can easily understand and apply. He is passionate about transforming technical information into engaging, accessible content that supports informed decision-making. With a strong emphasis on accuracy, clarity, and value, Alex strives to create content that earns readers’ trust and delivers meaningful results.

Please also review AIHCP’s Managed Health Care Certification program and CE courses see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

Written by Agwalogu Bob,

Osteoporosis is often called a “silent disease.” It’s called that because it can progress from one stage to the next without any noticeable symptoms. For older adults, it typically affects; however, the consequences are anything but silent.

For years, the treatment has always followed a fairly predictable path. Patients are encouraged to take calcium and vitamin D, stay active, or may be given an oral bisphosphonate. Those recommendations still work. But advances in healthcare mean that there are now different osteoporosis medications and therapies, which can be tailored to each patient.

This couldn’t come at a better time. As the population ages, the number of fragility fractures also rises. It is actually one of the biggest challenges facing geriatric care today. In fact, a 2025 BMJ study reveals that more than 10 million Americans over age 50 have osteoporosis. Another 43.4 million have low bone mass, and so are at a high risk of it.

This article discusses these leading treatment options, including some of the key factors that should guide your next prescribing decision.

The Growing Clinical Challenge in Older Adults

As we said earlier, osteoporosis is possibly one of the most common problems in geriatric care. Nearly 1 in 5 women over 50 have it, compared with about 1 in 25 men. This number climbs to 27.1% and 5.1% for women and men, respectively, after 65 years. That’s how common it is.

And the clinical stakes can be quite high. A hip fracture, the most devastating complication, comes with a 20% to 25% chance of being fatal within the first year. And it can rob people of their independence, leading to reduced mobility and a significant decline in quality of life, while at it. 

Many clinicians have seen it happen: a patient goes from living independently to needing full-time care after a fall. And that’s just the health and personal impact. The economic toll is also staggering, with estimated direct costs in the USA alone reaching around $25.3 billion in 2025. The figures may have changed today, but the overall picture is the same.

Because fracture prevention is really the whole point of treatment, choosing the right therapy for the right patient is one of the most important clinical decisions you’ll have to make in cases like these.

Understanding Modern Osteoporosis Treatment

Modern osteoporosis treatment begins with fracture prevention, which can only happen when you match the right medication to the right patient.

A few years ago, you would simply prescribe the same drug for everyone with low bone density. Not anymore. The preferred approach now is to treat patients based on their fracture risk and potential health benefits.

Doing this involves two major categories:

1. Antiresorptive therapies. These are medications that slow bone breakdown by reducing osteoclast activity. Examples include bisphosphonates, Prolia (denosumab), and Reclast (zoledronic acid). These medications work by preserving existing bone and reducing future fracture risk.
2. Anabolic therapies. These are bone-building medications. Instead of slowing breakdown, they actively stimulate new bone formation. Examples include Evenity (romosozumab), as well as the teriparatide and abaloparatide families of drugs.

So, how do you choose between antiresorptive therapy and anabolic therapy? Definitely not by considering bone mineral density alone.

You have to evaluate:

• Their fracture risk
• Bone mineral density (BMD)
• History of previous fractures
• Kidney function
• Their ability to adhere to treatment

Let’s not forget the elephant in the room. It is the cost and insurance considerations, which play a huge role in patient adherence.

Take antiresorptive therapies, for example. They’re a great fit for patients with a moderate to high fracture risk, which is why they’re so common among older adults. The problem is that out-of-pocket costs can be really high, and your patients may want to know if the treatments are covered by insurance. The short answer is yes. 

Coverage of part of the Prolia cost with Medicare, for example, only happens under Part B when given in a clinic, and under Part D. That’s the rule, and even so, coverage isn’t automatic. 

Documented medical necessity is needed to qualify for coverage, according to LIFE143. This means that you, as a doctor, must confirm that the patient has osteoporosis or is at high risk for fractures. You may also have to confirm that oral treatment failed or that the patient showed side effects of oral therapy. This confirmation ensures that Medicare processes the claims without delays or denials.

Comparing Today’s Leading Osteoporosis Medications

The biggest advance in osteoporosis treatment for older adults isn’t just in the arrival of new drugs and therapies. 

It’s also the fact that doctors can now tailor treatments to the patients. No more using the same one-size-fits-all approach for someone with mild osteopenia as for an 82-year-old who recently sustained a hip fracture.

In the table below, we’ll summarize some of today’s leading therapies and the key considerations for each.

Choosing the Right Therapy for Different Patient Profiles

The table above summarizes some of the top medications for osteoporosis today. The question now is: How do you pick? 

Simple, really. For a patient with moderate risk, a generic bisphosphonate is usually a solid, cost-effective starting point. But if you have a patient with a prior vertebral or hip fracture, you need to think bigger and potentially start with an anabolic agent. Expert opinion is actually shifting from a “step-up” approach to a “top-down” one for these high-risk individuals. This means initiating therapy with a potent anabolic agent for rapid protection.

But beyond the clinical problem, you also have to think about the person. This means looking at their life expectancy, functional status, and personal goals, not just their T-score. Following this approach, if a patient has renal impairment and can’t take oral bisphosphonates, Prolia becomes an obvious choice. 

At the end of the day, the best medication to choose is the one the patient will actually take. Adherence is everything.

Emerging Trends in Osteoporosis Management

Osteoporosis management has moved from vitamin D and calcium to antiresorptive and anabolic therapy, but that doesn’t mean it’s not going to evolve further, because it is. 

A good example is the research into sequential therapy, which is gaining steam. In a study published in Osteoporosis International, researchers found that sequencing treatments works. The combination of a bisphosphonate followed by romosozumab boosted spine bone density by over 10%. Romosozumab followed by denosumab (Prolia) also delivered solid gains, with spine BMD increasing by 4%.

Research is also looking at repurposing existing drugs, like with the antihistamine fexofenadine, which is showing great promise in promoting bone formation.

But over and above all of this, we’re moving towards increasingly personalized treatment plans. Dr. Gianina Flocco, a resident at the Cleveland Clinic, said at ENDO 2025, “The results of our study support the need to enhance the individualized initiation of treatment of osteoporosis, even in people who are older than 80.”

FAQs

What’s the main difference between antiresorptive and anabolic osteoporosis drugs?

The difference between antiresorptive drugs and anabolic drugs is in how they work. Anabolic drugs like romosozumab actively stimulate new bone formation, while antiresorptive drugs like Prolia slow down bone breakdown.

Is Prolia safe for patients with kidney disease?

Yes, it is. Prolia doesn’t require renal dose adjustment, which is why it’s common to recommend it for patients with reduced kidney function. However, even though it’s a twice-yearly shot, any benefits disappear rapidly if a dose is missed.

Does Medicare cover osteoporosis medications?

The short answer is yes. However, Medicare coverage is based on how the drug is administered. Part B means that it has to be administered in a clinical setting. Part D means it has to be administered as a prescription. Even then, the patient has to prove that the treatment is a medical necessity.

Final Words

Osteoporosis treatment has come a long way, and you can see just how far in this guide. With the antiresorptive and anabolic therapies now available across multiple drug classes, we now have more opportunities to give older adults a second chance at independence. The key is knowing how to match the right agent and the right sequence to the right patient.

Author Bio

Agwalogu Bob believes great content doesn’t just inform; it resonates and then sticks. For over eight years, he’s been helping agencies across four continents craft just that kind of content: sharp, engaging cut-through-the-noise copy across SaaS, finance, tech, health, and lifestyle.

When he’s not putting pen to paper, you’ll likely find him scouring the internet for funny memes.

Connect with him on LinkedIn or Medium.

Please also review AIHCP’s Certification program and CE courses see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

Written by Agwalogu Bob

If you run a medical practice, you know how difficult getting the right software is. Virtually every vendor you talk to will promise that their solution “streamlines workflows” and “enhances patient engagement.” But the truth is that the software purchase decisions you make today can make or mar your practice tomorrow. 

Buy wrong, and you’re not just losing thousands of dollars; you’ll also end up with frustrated staff and disgruntled patients. A recent study by the American Medical Association (AMA) also noted that administrative burdens, usually worsened by poorly integrated tech, can cause burnout among healthcare practitioners. Clearly, you cannot afford to make a blind guess.

This is exactly why you need healthcare software review platforms. They give you an unbiased picture of the healthcare software you’re considering, mostly from people who’ve used or are using it.

Let’s look at five of these platforms to help you make a more informed decision next time you want to onboard new software.

What is a Healthcare Software Review Platform?

A healthcare software review platform is a site where you go to research, compare, and choose software products for your medical practice or clinic. 

These platforms don’t sell or suggest market products directly. Instead, they break down product information, provide expert insights, and publish real user reviews so that you can make your own decision based on the data available. 

Healthcare software review platforms are basically where clinical practitioners go to get first-hand information about the IT tools other practitioners use, and how they work.

Using review platforms can help you:

• Compare multiple vendors in one place
• Read the real experiences of verified customers
• Identify hidden strengths and recurring complaints
• Shortlist products before scheduling demos

Industry reports show that as much as 95% of buyers read user reviews before making a purchase. This underscores how important review platforms are, especially in the higher-stakes healthcare industry.

5 Best Healthcare Software Review Platforms

Below are five of the best healthcare software review platforms that you can go to compare tools for medical practices and clinics.

G2

G2 is the world’s largest B2B software and services platform. It’s a trusted marketplace where professionals can research, compare, and read verified user reviews on thousands of technology solutions, including clinical healthcare software.

Healthcare software reviews on G2 go beyond feature lists. They show what it’s really like to use the software day after day, from setup and ease of use to customer support and reliability. 

The platform also ranks products based on customer satisfaction and market presence. This makes it easier for medical practices and clinics to spot solutions that consistently perform well. 

G2 currently boasts more than 2.8 million verified user reviews, clinching its place as a big contender in technology software reviews globally.

Key Points

• Verified reviews from healthcare professionals and software users
• Compare EHR, EMR, medical billing, and practice management software
• Side-by-side product comparisons and user satisfaction scores
• Real-world insights on usability, implementation, and customer support
• Helps you make more informed software purchasing decisions

Who It’s For

Medical practices, clinics, physicians, practice managers, and healthcare administrators who want trusted user feedback before investing in healthcare software.

Software Finder

Software Finder is a software review platform and marketplace that helps you find the right software quickly and without the usual trial and error.

Instead of comparing hundreds of vendors on your own, you can explore product information and compare verified user reviews on thousands of solutions, including medical practice software.

Software Finder also allows you to narrow your options based on rating type, price, and features in order to receive more relevant recommendations. This means that you end up buying your medical practice software with more confidence, backed by real user feedback and not just marketing claims.

Perhaps the most noteworthy feature of Software Finder is its Personalized Software Recommendations. If you’re not sure whether the software you’re looking at is right for your needs, simply complete a short form and get free advice in your email. 

Key Points

• Verified reviews from over thousands of real software users
• Side-by-side comparisons of healthcare software
• Thousands of software options across hundreds of categories
• Personalized software recommendations with the platform’s “Free Advice” feature
• Helps you save time and make informed purchasing decisions

Who It’s For

Private practices, specialty clinics, healthcare administrators, and medical organizations that want reliable, unbiased information before choosing healthcare software.

GetApp

GetApp, which was recently acquired by G2 in 2026,  is a software discovery and comparison platform for researching digital products. Although it covers software across many industries, it has a dedicated healthcare section where you can explore and research clinical tools.

GetApp allows you to compare medical practices and clinics software products side by side, check pricing, product information, and real user opinions before making a decision. This makes it easier to narrow down your options without spending hours visiting individual vendor websites. 

Whether you’re replacing existing software or buying a new system for the first time, GetApp gives you a practical starting point to make an informed decision.

Key Points

• Covers thousands of software products, including healthcare solutions
• Verified customer reviews and ratings
• Side-by-side feature and pricing comparisons
• Category-based software recommendations
• Free to use for software buyers

Who It’s For

Medical practices, clinics, and healthcare organizations that want to compare multiple software options before making a purchase.

KLAS Research

KLAS Research is an independent healthcare IT research website that functions very much like a specialized software review and evaluation platform. 

KLAS provides the healthcare industry with IT data and insights, but it also makes it easy for medical practices and clinics to choose healthcare technology with confidence. This is possible through the countless detailed reviews published from thousands of healthcare practitioners and professionals who use these systems every day. 

These reviews include information on customer support, product reliability, and long-term satisfaction. All in all, KLAS gives you a clearer picture of what works well in real clinical settings before you make any purchase decision.

Key Points

• Collects verified feedback from real healthcare professionals
• Publishes trusted Best in KLAS software rankings
• Reviews EHRs, practice management, billing, and other healthcare solutions
• Focuses on real-world performance after implementation
• Helps reduce the risk of choosing the wrong software vendor

Who It’s For

Medical practices, clinics, hospitals, healthcare executives, IT decision-makers, and organizations that want reliable, evidence-based insights before investing in healthcare software.

Software Advice

Software Advice is an independent platform that provides research, consultancy, and reviews for software products. It provides objective insights, verified user reviews, technical support, and personalized software recommendations across more than 300 categories, including healthcare.

Software Advice doesn’t promote any one single product or service. Instead, it brings together all the important information you need to make an informed decision about software for your healthcare practice. 

One of its biggest strengths is its free advisory service. This service matches you with software recommendations that fit your specific needs. It comes in very handy if you’re comparing several vendors that appear similar at first glance.

Key Points

• Compares hundreds of thousands of software in one place, including healthcare
• Includes verified customer reviews and expert opinions
• Offers side-by-side feature comparisons of different digital products
• Provides pricing insights
• Helps you shortlist software that fits your needs

Who It’s For

Practice owners, clinic administrators, physicians, office managers, and healthcare teams that want to compare healthcare software before making a purchase.

How to Use Healthcare Software Review Platforms

The right review platform can help you find the software that matches your specific buying stage and clinical needs. In fact, recent research revealed that for 90% of software buyers, social proof, including customer reviews and ratings, heavily influences which vendors they choose.

The problem? There are hundreds of healthcare software review platforms (we’ve only covered the best 5), and thousands of digital products on each one. 

How exactly do you choose right?

Use this checklist before making your shortlist:

• Look for platforms with verified customer reviews, not anonymous ratings
• Read both positive and negative feedback
• Compare reviews across at least three platforms
• If you can, filter reviews by organization size or medical specialty
• Pay close attention to information about the vendor’s customer support
• Request product demos after narrowing your shortlist
• If possible, chat with current customers before signing any contract
• Don’t get immediately carried away by star ratings

Ultimately, review platforms should support your decision, not make it for you.

FAQs

Are online software reviews actually reliable?

Absolutely. However, you have to use trusted sites. Platforms like Software Finder verify users to filter out fake reviews. That said, you should still do your part by doing more in-depth research. Don’t get carried away by a single glowing or angry comment.

Can I find pricing information on these review platforms?

Yes, you can. Having said that, it’s important to point out that healthcare software pricing is rarely one-size-fits-all. While some platforms list basic pricing models, the total amount you end up paying will depend on the unique needs of your practice or the number of features you want.

Are healthcare software review platforms free to use?

Yes, but for buyers. Most platforms let you browse reviews and comparisons at no cost. Vendors, however, may have to pay for enhanced listings or advertising.

Wrapping Up

Choosing software for your medical practice isn’t something to gamble on. The right healthcare software review platform gives you a shortcut past the sales pitch and straight to what other practices actually experienced.

To help you get started, we’ve covered five of the best healthcare software review platforms for medical practices and clinics here in this guide. 

Don’t just read one review and think you’ve found what you’re looking for. Take your time and look at at least three vendors. You want to end up with tools that will truly help your medical practice thrive.

Author Bio

Agwalogu Bob believes great content doesn’t just inform; it resonates and then sticks. For over eight years, he’s been helping agencies across four continents craft just that kind of content: sharp, engaging cut-through-the-noise copy across SaaS, finance, tech, health, and lifestyle.

When he’s not putting pen to paper, you’ll likely find him scouring the internet for funny memes.

Connect with him on LinkedIn or Medium.

Please also review AIHCP’s Certification program and CE courses see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

Written by Elissa Capelle Vaughn

When we think of medicine, often the first thing that springs to mind is “illness.” From this perspective, patients visit a doctor when they have a symptom, like a persistent pain or stomach bug. But on the other side of this approach is medicine as a proactive tool, and that’s where performance medicine comes in.   

Performance medicine is an integrative practice that combines sports medicine, functional medicine, and even anti-aging studies to enhance well-being. It also appeals to multiple patients, from athletes who want to achieve peak health to individuals who want targeted care for longevity.

When paired with traditional general healthcare, performance medicine fosters a truly holistic approach to health. Here’s a closer look at core components, comparisons, practices, and case studies of performance medicine.       

Performance Medicine vs. Internal Medicine

Let’s start with distinguishing the similarities and differences between performance medicine and internal medicine.

For starters, both practices strictly rely on evidence-based care. Internal medicine treats illnesses and health conditions, but like performance medicine, it also focuses on:

• Prevention
• Nutrition
• Sleep
• Diagnostics
• Lifestyle changes

Both practices share the same goal in improving long-term health outcomes and reducing the risk of injury. Performance medicine practitioners and general physicians both conduct comprehensive assessments, including: 

• Lifestyle evaluations
• Hormone levels
• Metabolic health 

Of course, both physicians maintain high levels of trust with patients to foster the best possible outcomes.    

As for key differences, while internal medicine does involve preventative care, it’s also a “reactive” process that must diagnose and treat symptoms quickly. Performance medicine is a “proactive” practice that enhances physical and mental performance, such as:

• Adaptive capacity
• Endurance
• Mental acuity
• Stamina
• Longevity

Patient segments also differ, with performance medicine generally targeting individuals with low health risks who want to enhance their health. 

An athlete may seek out a performance medicine practice to boost their endurance or mental grit. Active older adults may also work with a performance medicine doctor to manage the impacts of aging through peptide therapy and weight management. 

Women in general good health may also take a proactive approach and seek a performance medicine clinic for menopause care. While an internal medicine physician can help the same female patient manage menopause symptoms, a performance medicine professional can help balance hormones and promote healthy metabolism.  

Performance Medicine vs. Sports Medicine

At first glance, the term “performance medicine” may be confused with sports medicine, but there are distinct differences.

Let’s start with the similarities, with the clearest being strength and endurance, followed by: 

• Proactive injury prevention
• Nutrition
• Health monitoring

For example, a sports medicine doctor will also monitor hormone levels, nutrition, and musculoskeletal health to improve performance and prevent burnout. Monitoring also speaks to the level of individualized care seen in performance medicine, as well. 

One of the clearest differences is “return to play” care. 

Sports medicine is primarily concerned with treating sports injuries and getting professional and collegiate athletes back on the field. Sports medicine doctors often work in teams to answer whether an athlete can jump, throw, and sprint again, and if so, when?

Depending on the severity of a sports injury, a sports medicine team may require surgical or orthopedic treatments.   

As such, sports medicine patients are primarily athletes. Performance medicine targets a wider range of patient profiles, from the high-level executive managing corporate stress to the mother who’s navigating perimenopause while trying to keep up with a busy household.

A valuable takeaway is that sports medicine has a narrower, short-term approach to resilience, while performance medicine focuses on long-term resilience.   

It should also be noted that many performance medicine doctors do train in sports medicine, internal medicine, or physical medicine & Rehabilitation (PM&R) before entering their chosen field. They may pursue performance medicine as a sub-specialization through a sports medicine fellowship, for example.    

Performance Medicine vs. Medical Spas

Performance medicine also shares similarities with medical spas (medspas), with notable differences.  

A common similarity is an integrative approach, as seen in the case study of Moonshot Medical and Performance, a medical optimization and physical rehabilitation clinic. Similar to some medspas, this case study integrates the following approaches into weight management programs: 

• GLP-1 medications
• Nutrition guidance
• Dual-Energy X-ray Absorptiometry (DEXA) scans

DEXA scans are comprehensive health reports that compare patient results with appropriate age and sex ranges. Patients see a more accurate view of fat and muscle distribution. DEXA tracking is then used to develop plans and monitor progress. 

It’s important to note that performance medicine clinics apply strict medical scrutiny in practice. This is a key differentiator between performance medicine clinics like the case study and some medspas. 

For instance, a general wellness center may offer massage therapy, but lack the medical oversight to provide GLP-1 plans. Similarly, while many medical spas do offer weight loss management, they may not have an on-site physician to diagnose and prescribe a GLP-1 like Semaglutide. 

Anti-aging treatments are another overlap. 

For example, the performance medicine clinic in the case study provides peptide-based therapy for anti-aging. Peptides are naturally occurring amino acids in the body; therapeutic peptides like GHK-CU mimic natural peptide signals to simulate the collagen synthesis process, promoting skin elasticity and hair growth.   

A medical spa may offer peptide anti-aging therapies with the right medical oversight. However, most spas focus on cosmetic treatments like dermal fillers and skin resurfacing. Performance medicine takes a more rigorous inside-out approach to health and wellness.

Performance medicine clinics may vary when it comes to treatments, with some offering cold plunges to relieve inflammation, while others may focus on HRT treatments for hormone balance. However, the goal of medical optimization remains unchanged. 

Blood Panels and Labwork in Performance Medicine  

Similar to internal medicine, performance medicine clinics run bloodwork to get a clearer picture of a patient’s health status. However, performance medicine labwork looks beyond statistical averages based on population data. Instead, it looks at optimal health ranges to set benchmarks. 

Consider this scenario: A patient visits their doctor, a general physician, citing issues with fatigue and longer recovery times from muscle strain. 

The GP runs a blood panel, revealing testosterone levels on the lower end and cortisol levels on the higher end, but these levels are still within the “normal” range, despite the rise and falls. The GP may tell the patient that their levels are normal and likely to balance out. 

The patient decides to see a performance medicine physician. 

The physician looks at the blood panel and sees the subclinical dysfunction in the testosterone and cortisol levels. They create a treatment plan consisting of bioidentical hormone therapy (BHRT) and targeted stress mitigation to restore the patient’s anabolic drive, which should help the body build and repair tissue while controlling hormones. 

Lab-informed decision-making is a core pillar of performance medicine.

Performance medicine physicians order advanced blood panels that test beyond the standard 15 markers used by internal medicine. Advanced panels test over 60 biomarkers, including: 

• ApoB for cardiovascular health risk
• Fasting insulin for metabolic health
• Sex hormone metabolites

Meanwhile, genetics and epigenetics tests offer important insight into genetic predispositions. This allows performance medicine practitioners to customize targeted lifestyle interventions early. 

Data Analysis in Performance Medicine

Blood tests provide valuable patient data for treatment plans, but continuous monitoring ensures that data is current and relevant. 

Performance medicine doctors perform objective blood re-testing and DEXA scans every few months to analyze treatment progress. For instance, if lipid levels remain unchanged, they may administer PCSK9 Inhibitors.  

Biometric dashboards are used to monitor the autonomic nervous system (ANS), which regulates involuntary processes, such as: 

• Resting heart rate (RHR)
• Heart rate variability (HRV)
• Respiratory Rate
• Blood Pressure 
• Sudomotor Function (Sweat Response)

Patient-reported outcomes (PROMs) are also vital to data analysis in performance medicine. These digital surveys ensure data actually aligns with a patient’s daily life, tracking patterns in sleep quality, mental clarity, and pain impact.

Rehabilitation and Recovery in Performance Medicine

In internal medicine, a patient’s physical therapy treatment typically ends once they’re able to perform daily tasks and go to work without pain. If they want to improve their strength beyond their PT sessions, they can see a performance medicine doctor for targeted strength and endurance regimens.  

For instance, a practitioner may use load management techniques to stress the patient’s tissues just enough to improve muscle adaptation. The goal is to strengthen the muscle without re-injuring the area. But the ultimate goal is greater resilience, lowering overall injury risk.

Performance medicine also takes an active, rather than passive, approach to recovery. A doctor may recommend contrast therapy, which combines infrared sauna sessions and cold plunges to: 

• Promote better vascular health
• Detoxify the system 
• Trigger norepinephrine release
• Reduce overall inflammation

Hyperbaric oxygen therapy (HBOT) is also used in performance medicine to speed up healing and cellular repair in the body, treating the whole person.

All three of these methods help downregulate the nervous system and flush out metabolic waste.

Learn More About Performance Medicine

Performance medicine stands out as an integrative practice that considers the whole person, whether it’s a patient who wants to build up strength after physical therapy, a woman entering menopause, or a busy corporate professional trying to reduce toxic stress. 

Research further into its similarities and differences with other practices, clinical tests, data analysis, and recovery. Our blog is packed with information on sectors, career pathways, and innovations in the healthcare community. 

Author bio:

Elissa Capelle Vaughn is a New York-based content writer who covers trending topics in health and wellness. She also brings a diverse background in sales and marketing to her work when discussing communication strategies in the health field.

Please also review AIHCP’s Managed Health Care Consultant Certification program and CE courses see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

Written by Harry Wolf

Onychomycosis affects around 10 to 20 percent of the global population. It also makes up about 50 percent of all nail disorders, according to a 2025 report published by the International Journal of Advanced Biochemistry Research.

Age-related nail changes, reduced peripheral circulation, cumulative environmental exposure, and comorbid disease… They all contribute to the condition’s prevalence. 

Therapeutic decisions are rarely straightforward for clinicians. Efficacy, pathogen identification, comorbidities, drug interaction potential, laboratory monitoring requirements, adherence capacity, and cost… All influence selection between oral and topical antifungal therapies.

A Brief Overview of Onychomycosis

What exactly is onychomycosis? If you are not aware, here is the lowdown: it is a chronic fungal infection involving the nail plate, nail bed, and (in advanced cases) the nail matrix. 

Dermatophytes remain the most common etiologic agents, although non-dermatophyte molds and yeasts are increasingly identified in laboratory-confirmed cases, as detailed in an interesting analysis published by Nature’s Scientific Reports. 

Accurate organism identification has become increasingly important. Why is that? Quite simply, because therapeutic response varies by species.

Clinically, onychomycosis presents in several morphologic patterns. The following patterns influence both severity assessment and treatment selection:

• Distal lateral subungual disease with progressive onycholysis
• Superficial white onychomycosis affecting the dorsal nail plate
• Proximal subungual disease
• Total dystrophic onychomycosis in advanced and long-standing infections

Chronic fungal colonization can produce subungual hyperkeratosis, nail thickening, discoloration, and friability. Functional consequences include pain, difficulty ambulating, and impaired quality of life. 

In patients with diabetes, neuropathy, or peripheral arterial disease, thickened dystrophic nails may contribute to ulceration risk.

Diagnostic confirmation is recommended before initiating systemic therapy. 

Antifungal Therapies

Antifungal therapies for onychomycosis are categorized as systemic oral agents or topical transungual therapies. Selection should be determined by:

• Disease severity
• Nail matrix involvement
• Organism type
• Comorbidities
• Patient preference

Systemic agents achieve therapeutic concentrations in the nail bed via bloodstream distribution. 

An evidence-based review, published by the National Library of Medicine, confirms that terbinafine, itraconazole, and fluconazole demonstrate clinically meaningful efficacy in treating onychomycosis. 

Cure rates? They are generally higher with systemic therapy in moderate-to-severe disease – compared with topical monotherapy.

Topical therapies act directly at the site of infection. A study published by Springer Nature demonstrated superior transungual penetration and antifungal activity of efinaconazole compared with tavaborole, ciclopirox, and several over-the-counter options. 

Penetration capacity is clinically relevant. Why? Because the nail plate presents a dense keratin barrier.

Therapeutic strategies? They may include:

• Continuous oral dosing regimens lasting 6 to 12 weeks
• Pulse-dosed oral therapy administered in treatment cycles
• Daily topical application for 48 weeks or longer
• Combination systemic and topical approaches in refractory cases

Mechanistically, allylamines such as terbinafine inhibit squalene epoxidase. They can lead to:

• Ergosterol depletion
• Fungal cell membrane disruption

Azoles such as itraconazole inhibit lanosterol 14-alpha-demethylase, thus impairing ergosterol synthesis. And oxaboroles such as tavaborole inhibit fungal protein synthesis by targeting leucyl-tRNA synthetase.

Understanding pharmacodynamics supports rational therapeutic selection – particularly in complex or recurrent cases, that is.

Selecting Oral Antifungal Therapies

When multiple nails, matrix involvement, or extensive subungual hyperkeratosis are present, systemic therapy remains a first-line approach. Treatment selection needs a high level of attention. 

It requires careful evaluation of:

• Efficacy data
• Safety profile
• Comorbid disease
• Drug interaction potential

The Comparative Efficacy of Oral Agents

Multiple comparative trials and meta-analyses demonstrate the following. Continuous oral terbinafine produces higher mycologic and complete cure rates than intermittent itraconazole in dermatophyte toenail onychomycosis.

A double-blind randomized clinical trial, published by the Institute of Tropical Medicine, is worth noting. It compared terbinafine 250 mg daily for 12 weeks with itraconazole 200 mg daily for 12 weeks. 

The study reported significantly higher negative mycology rates at 48-week follow-ups in the terbinafine group – 73% versus  46%, in fact. Plus, there were higher rates of near-total clinical cure as well. 

These findings support continuous terbinafine as a preferred first-line agent in dermatophyte-predominant disease.

Long-term follow-up data published in JAMA Dermatology further demonstrates that terbinafine can achieve significantly higher sustained mycologic and clinical cure rates, compared with itraconazole, that is. There were lower relapses observed over extended observation periods. 

Sustained clearance is clinically meaningful. And that is because? Recurrence contributes to repeated systemic exposure and cumulative cost.

Key comparative considerations? They include:

• Higher sustained mycologic cure rates with continuous terbinafine
• Lower relapse rates in long-term follow-up with terbinafine
• Broader organism coverage with itraconazole
• Dosing flexibility with pulse itraconazole regimens

Yes, itraconazole remains an effective alternative – particularly when non-dermatophyte molds or yeasts are implicated, that is. However… continuous terbinafine therapy continues to demonstrate superior efficacy outcomes in dermatophyte-associated toenail infection.

Safety Profiles and Monitoring

Oral antifungals… They require attention to hepatic safety and drug interaction potential. A safety-focused review published by the National Library of Medicine confirms that terbinafine and itraconazole are generally well tolerated but associated with rare hepatotoxic events. 

Hepatic injury is uncommon, yes. But it is clinically significant. So, it warrants appropriate screening.

Baseline liver-function testing is widely recommended before initiating systemic therapy. Monitoring intervals vary depending on the:

• Duration of therapy
• Patient-specific risk factors

Important safety considerations include:

• CYP3A4 inhibition and interaction potential with itraconazole
• Rare hepatotoxicity associated with terbinafine
• Possible negative inotropic effects with itraconazole
• Polypharmacy concerns in older adults

Special Populations and Comorbidities

Patients with diabetes… They represent a clinically significant subgroup. Thickened, dystrophic nails may increase pressure points and contribute to ulcer risk. 

Effective fungal eradication may reduce mechanical complications in this population.

Immunocompromised patients may experience atypical or proximal subungual presentations. Broader-spectrum coverage may be considered when non-dermatophyte pathogens are suspected.

Oral therapy may be less suitable in:

• Active or chronic hepatic disease
• History of medication-induced hepatotoxicity
• Inability to adhere to monitoring protocols
• Patient preference for localized therapy

Selecting Topical Antifungal Therapies

Topical therapy… It plays a central role in mild-to-moderate onychomycosis and in patients who cannot tolerate systemic agents. Localized therapy minimizes systemic exposure. However, it requires sustained adherence and realistic counseling regarding duration.

Indications for Topical Monotherapy

Topical monotherapy is typically reserved for limited nail involvement without matrix infection. Treatment duration often approaches 48 weeks because nail growth is slow and drug penetration through keratin is limited.

Appropriate candidates may include:

• Involvement of less than 50 percent of a single nail
• Absence of matrix involvement
• Contraindications to systemic therapy
• Preference to avoid systemic adverse effects

Comparative Effectiveness of Topical Agents

Let’s now reference laboratory evidence published by Springer Nature. It demonstrated significantly greater antifungal activity and transungual penetration for efinaconazole compared with tavaborole, ciclopirox, and evaluated over-the-counter products. 

Enhanced penetration may improve mycologic clearance – in carefully selected patients, that is.

Also, the study published by the  International Journal of Advanced Biochemistry Research, which we referenced earlier, emphasizes relapse risk and identifies adherence as a primary determinant of success. 

Prolonged daily application is required. For what reason? To maintain therapeutic drug levels in the nail plate.

Prescription options include:

• Efinaconazole 
• Tavaborole 
• Ciclopirox 

Clinical selection depends on severity, penetration profile, and tolerability – as well as financial accessibility. So, if you are looking for products containing the active ingredient of efinaconazole, such as Jublia, for example, consider all those elements.

Reviewing the cost of Jublia at PricePro Pharmacy could assist patients in aligning their therapy with affordability.

Combination Therapy and Adjunctive Measures

Combination therapy may be considered in recalcitrant cases. Concomitant topical therapy during or after systemic treatment may reduce recurrence risk – by suppressing residual fungal elements, that is.

Adjunctive strategies? They include:

• Mechanical debridement to reduce nail thickness
• Regular trimming to decrease fungal burden
• Treatment of concomitant tinea pedis
• Environmental hygiene to reduce reinfection

Addressing concomitant skin infection reduces the likelihood of nail reinoculation.

Adherence 

Adherence remains a significant barrier in topical therapy. Daily application for extended periods requires sustained patient engagement.

Clinical reviews highlight:

• Nearly year-long treatment timelines
• Gradual cosmetic improvement rather than rapid change
• Higher relapse rates compared with systemic therapy

Clear communication regarding expected time frames and visible milestones is crucial. Because? It improves persistence and therapeutic satisfaction.

Evolving Dermatophyte Resistance Patterns 

Emerging antifungal resistance is increasingly influencing clinical decision-making in onychomycosis management. Clinically relevant considerations include:

• Refractory infection despite confirmed adherence
• Recurrence shortly after completing systemic therapy
• History of travel to areas with reported resistant strains
• Prior prolonged or repeated terbinafine exposure

Itraconazole is frequently utilized as an alternative systemic agent when terbinafine resistance is suspected. In documented resistant cases, switching antifungal class has demonstrated clinical improvement. 

Molecular diagnostic tools and susceptibility testing may become increasingly relevant in tertiary-care and academic settings.

Also, antifungal resistance reinforces the importance of avoiding empiric systemic therapy without laboratory confirmation. Confirmed diagnosis prior to initiation minimizes unnecessary exposure. And it may reduce selective pressure that contributes to resistance development.

Recurrence Prevention and Long-Term Management 

Recurrence remains a persistent challenge in onychomycosis management. Even after an apparent clinical cure. 

Data indicates relapse rates of approximately 20 to 25 percent within two years following successful treatment, as summarized in that study published by the International Journal of Advanced Biochemistry Research. 

For clinicians, a durable cure requires attention beyond initial fungal eradication.

According to an article by Infection and Drug Resistance, recurrence may be influenced by:

• Biofilm formation
• Untreated concomitant tinea pedis
• Persistent environmental reservoirs
• Host factors such as immunosuppression or diabetes

Addressing those elements can improve long-term outcomes. 

Preventive strategies include:

• Treating coexisting tinea pedis concurrently
• Encouraging proper foot hygiene and drying practices
• Disinfecting footwear and nail-care instruments
• Monitoring high-risk patients periodically after cure

Patients with diabetes, peripheral vascular disease, or immunosuppression may require closer follow-ups. Why is that? Quite simply, it is due to elevated complication risk. 

Maintenance topical therapy following systemic treatment has been explored as a strategy to reduce recurrence, particularly in individuals with repeated relapse.

Environmental reinoculation also plays a role in recurrence. Shared showers, occlusive footwear, and persistent fungal reservoirs in socks or shoes may facilitate reinfection. Counseling patients about these risks will help to improve long-term therapeutic durability.

Recurrence prevention represents a shift from episodic treatment toward longitudinal management. Integrating preventive counseling into routine care:

• Supports sustained remission
• Reduces cumulative treatment burden

Applying Clinical Judgment in Onychomycosis Management

Let’s recap. Firstly, effective onychomycosis management requires individualized assessment – rather than protocol-driven uniformity, that is. 

Oral antifungal therapy generally provides higher complete cure rates in moderate-to-severe disease. Topical antifungal therapy offers a valuable alternative for localized infection or when systemic agents are contraindicated.

Diagnostic confirmation, organism identification, safety monitoring, adherence counseling, and financial accessibility… They all influence therapeutic success. 

Hopefully, this article has been helpful. If it has been, take a look at our other relevant content.

Author bio: Harry Wolf is a freelance writer. For almost a decade, he has written on topics ranging from healthcare to business leadership for multiple high-profile websites and online magazines.

References

• Unauthored, 2022, Toenail Fungus, Cleveland Clinic.

https://my.clevelandclinic.org/health/diseases/11303-toenail-fungus

• Unauthored, 2024, Toenail fungus (onychomycosis), Harvard Health Publishing.

https://www.health.harvard.edu/a_to_z/toenail-fungus-onychomycosis-a-to-z

• Bodman, M. A., Syed, H. A., & Krishnamurthy, K., 2025, Onychomycosis, National Library of Medicine.

https://www.ncbi.nlm.nih.gov/books/NBK441853/

• Sinha, R., Rathaur, H., & Mukhopadhyay, S., 2025, Onychomycosis focus in the elderly: Prevalence, diagnosis and treatment strategies, International Journal of Advanced Biochemistry Research.

https://www.biochemjournal.com/archives/2025/vol9issue6/PartB/9-5-104-852.pdf

• Mayengo, R., Petra, N. P., Joseph, O., Ogwang, E., Kitunzi, G. M., Onguti, A. G., & Mirembe, S. K., 2025, Onychomycosis prevalence etiology and associated factors in women using nail cosmetics attending Mbarara regional referral hospital dermatology clinic Uganda, Nature.

https://www.nature.com/articles/s41598-025-30250-8

• De Sa, D. C., Lamas, A. P., & Tosti, A., 2014, Oral therapy for onychomycosis: an evidence-based review, National Library of Medicine.

https://www.ncbi.nlm.nih.gov/books/NBK189719/

• Elabbasi, A., Kadry, A., Joseph, W., Elewski, B., & Ghannoum, M., 2024, Transungual Penetration and Antifungal Activity of Prescription and Over-the-Counter Topical Antifungals: Ex Vivo Comparison, Springer Nature.

https://link.springer.com/article/10.1007/s13555-024-01237-6

• De Backer, M., De Keyser, P., De Vroey, C., & Lesaffre, E., 1996, A 12-week treatment for dermatophyte toe onychomycosis: terbinafine 250 mg/day vs. itraconazole 200 mg/day – a double-blind comparative trial, Institute of Tropical Medicine Antwerp.

https://research.itg.be/en/publications/a-12-week-treatment-for-dermatophyte-toe-onychomycosis-terbinafin/

• Sigurgeirsson, B., Ólafsson, J. H., Steinsson, J. Þ., Paul, C., Billstein, S., & Evans, E. G. V., 2001, Long-term Effectiveness of Treatment With Terbinafine vs Itraconazole in OnychomycosisA 5-Year Blinded Prospective Follow-up Study, JAMA Network.

https://jamanetwork.com/journals/jamadermatology/fullarticle/478735

• Gupta, A. K., Haas-Neill, S., & Talukder, M., 2023, The safety of oral antifungals for the treatment of onychomycosis, National Library of Medicine.

https://pubmed.ncbi.nlm.nih.gov/37925672/

• Axler, E., & Lipner, S. R., 2024, Antifungal Selection for the Treatment of Onychomycosis: Patient Considerations and Outcomes, Infection and Drug Resistance.

https://www.tandfonline.com/doi/pdf/10.2147/IDR.S431526

Please also review AIHCP’s Managed Health Care Consultant Certification program and CE courses see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification